Subscribe To Our Free Newsletter |
Hot Stocks: Brokerage view on Kotak Mahindra, Glenmark Pharma, Biocon and RIL
The risk-to-reward ratio is unfavourable at current levels. Earnings downgrades will continue due to a lack of new launches.